Key result
An office-based risk scoring system replacing lipid profiles with body mass index accurately discriminated individuals at high versus low risk of fatal cardiovascular disease with an AUC of 0.774.
Why the study?
Does an office-based Framingham risk scoring system accurately predict the 10-year risk of fatal cardiovascular diseases in an Iranian cohort?
Cohort (n=46,674)
Does an office-based Framingham risk scoring system accurately predict the 10-year risk of fatal cardiovascular diseases in an Iranian cohort?
Effect estimate: AUC 0.774 (95% CI 0.762-0.787)
An office-based risk scoring system using body mass index instead of lipid profiles showed good discrimination for predicting 10-year fatal cardiovascular disease risk in an Iranian cohort.
May support lab-free CVD risk assessment in primary care; leaves open need for external validation beyond Iranian cohorts.
BACKGROUND: Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran. METHODS: The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring method: sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed. RESULTS: A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI: 0.762-0.787) in all participants, 0.772 (95% CI: 0.753-0.791) in women, and 0.763 (95% CI: 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI: 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed. CONCLUSION: The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD.
No takes yet. Share an insight, caveat, or question.
Sepanlou et al. (2015) conducted a cohort in Cardiovascular diseases (n=46,674). Office-based Framingham risk scoring system was evaluated on 10-year risk of fatal cardiovascular diseases (discrimination) (AUC 0.774, 95% CI 0.762-0.787). An office-based risk scoring system replacing lipid profiles with body mass index accurately discriminated individuals at high versus low risk of fatal cardiovascular disease with an AUC of 0.774.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: